CREB1 and breast carcinoma: During the past few years, we have developed a number of cell-permeable first-generation and second-generation small molecule CREB inhibitors17, 18, 19, 20, 21, 22, some of which have been evaluated for anti-breast cancer efficacy in human xenograft models in mice18, 22.